Article

marketwatch.com on 2019-05-08 14:40

Gilead strikes deal with biotech Goldfinch Bio to tackle kidney diseases

Gilead Sciences Inc. and biotech Goldfinch Bio Inc. are striking a deal to develop and commercialize a pipeline of drugs for kidney diseases, the ...

Related news